{"id":"charcotrace-inj","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Charcotrace appears to be a specialized diagnostic tracer or contrast agent designed for neuroimaging applications, likely used in conjunction with imaging modalities to identify neural damage, demyelination, or other neuropathological changes. The name suggests a connection to Charcot disease or related neurological conditions, indicating its use in diagnostic assessment rather than therapeutic intervention.","oneSentence":"Charcotrace is a diagnostic imaging agent used to visualize and trace neural pathways and lesions in the central and peripheral nervous system.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:05:29.236Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diagnostic imaging of neurological lesions and neural pathways"}]},"trialDetails":[{"nctId":"NCT04606329","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions(Phase 3)","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2020-07-20","conditions":"Breast Diseases","enrollment":109},{"nctId":"NCT03743259","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2018-05-29","conditions":"Breast Diseases","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Charcotrace Injection(Activated Charcoal 40mg/1ml)"],"phase":"phase_3","status":"active","brandName":"Charcotrace Inj.","genericName":"Charcotrace Inj.","companyName":"Hanlim Pharm. Co., Ltd.","companyId":"hanlim-pharm-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Charcotrace Inj. is a medication used to treat breast diseases, as indicated by a clinical trial on ClinicalTrials.gov. The exact mechanism of action of Charcotrace Inj. is not specified in the provided facts, but it is being studied in a clinical trial alongside LuminoMark inj.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":2,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}